NO970039L - Method of inhibiting cancer metastases by oral administration of soluble modified citrus pectin - Google Patents

Method of inhibiting cancer metastases by oral administration of soluble modified citrus pectin

Info

Publication number
NO970039L
NO970039L NO970039A NO970039A NO970039L NO 970039 L NO970039 L NO 970039L NO 970039 A NO970039 A NO 970039A NO 970039 A NO970039 A NO 970039A NO 970039 L NO970039 L NO 970039L
Authority
NO
Norway
Prior art keywords
oral administration
citrus pectin
inhibiting cancer
cancer metastases
soluble modified
Prior art date
Application number
NO970039A
Other languages
Norwegian (no)
Other versions
NO311493B1 (en
NO970039D0 (en
Inventor
Avraham Raz
Kenneth J Pienta
Original Assignee
Karmanos B A Cancer Inst
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23037234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970039(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Karmanos B A Cancer Inst, Univ Wayne State filed Critical Karmanos B A Cancer Inst
Publication of NO970039D0 publication Critical patent/NO970039D0/en
Publication of NO970039L publication Critical patent/NO970039L/en
Publication of NO311493B1 publication Critical patent/NO311493B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for the treatment of cancer in mammals. A subject afflicted with cancer receives by oral administration a pH modified citrus pectin which inhibits metastasis of primary tumors.
NO19970039A 1994-07-07 1997-01-06 Use of modified pectin for the manufacture of a drug for the treatment or prevention of cancer NO311493B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/271,821 US5834442A (en) 1994-07-07 1994-07-07 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
PCT/US1995/007547 WO1996001640A1 (en) 1994-07-07 1995-06-14 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

Publications (3)

Publication Number Publication Date
NO970039D0 NO970039D0 (en) 1997-01-06
NO970039L true NO970039L (en) 1997-02-17
NO311493B1 NO311493B1 (en) 2001-12-03

Family

ID=23037234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970039A NO311493B1 (en) 1994-07-07 1997-01-06 Use of modified pectin for the manufacture of a drug for the treatment or prevention of cancer

Country Status (16)

Country Link
US (2) US5834442A (en)
EP (1) EP0768885B1 (en)
JP (1) JP2008111002A (en)
CN (1) CN1157567A (en)
AT (1) ATE276753T1 (en)
AU (1) AU695677B2 (en)
BR (1) BR9508245A (en)
CA (1) CA2194586A1 (en)
DE (1) DE69533550T2 (en)
DK (1) DK0768885T3 (en)
ES (1) ES2227555T3 (en)
FI (1) FI965269L (en)
MX (1) MX9700118A (en)
NO (1) NO311493B1 (en)
PT (1) PT768885E (en)
WO (1) WO1996001640A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107222A1 (en) * 1993-03-01 2002-08-08 David Platt Modified polysaccharides for treatment of cancer
BR9708122A (en) * 1996-03-21 2000-01-18 David Platt Modified pectic material
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US6500807B1 (en) 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
KR100401456B1 (en) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity
EP1261354A4 (en) * 2000-02-01 2004-09-15 Safescience Inc Delivery system and methods for gene therapy
DE10057976B4 (en) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Process for the preparation of pectin hydrolysis products
US6982255B2 (en) * 2001-03-27 2006-01-03 Anatole Klyosov Delivery of a therapeutic agent in a formulation for reduced toxicity
US6645946B1 (en) * 2001-03-27 2003-11-11 Pro-Pharmaceuticals, Inc. Delivery of a therapeutic agent in a formulation for reduced toxicity
ES2376739T3 (en) * 2001-03-27 2012-03-16 Galectin Therapeutics Inc. Joint administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US6914055B2 (en) * 2001-03-27 2005-07-05 Anatole Klyosov Delivery of a therapeutic agent in a formulation for reduced toxicity
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies
US20030004132A1 (en) * 2001-06-22 2003-01-02 Yan Chang Method and material for treating immune diseases
US20030109464A1 (en) * 2001-09-28 2003-06-12 Huflejt Margaret E. Galectins -1 and -4 in tumor development
US6890906B2 (en) * 2001-11-21 2005-05-10 Glycogenesys, Inc. Method for controlling angiogenesis in animals
US20040121981A1 (en) * 2001-11-21 2004-06-24 Glycogenesys, Inc. Method for controlling angiogenesis in animals
EP1592432A2 (en) * 2003-01-16 2005-11-09 Pro-Pharmaceuticals, Inc. Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer
WO2004087121A2 (en) * 2003-03-28 2004-10-14 Azaya Therapeutics, Inc. Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
WO2004091634A1 (en) 2003-04-07 2004-10-28 Glycogenesys, Inc. Composition and uses of galectin antagonists
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
US20050043272A1 (en) * 2003-07-11 2005-02-24 Pro-Pharmaceuticals, Inc. Compositions and methods for hydrophobic drug delivery
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US20050282773A1 (en) * 2004-01-14 2005-12-22 Pro-Pharmaceuticals, Inc. Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer
WO2005079314A2 (en) * 2004-02-13 2005-09-01 Pro-Pharmaceuticals, Inc. Compositions and methods used to treat acne and candida
WO2005095463A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
JP2008503583A (en) * 2004-06-22 2008-02-07 プロ−ファーマシューティカルズ，インコーポレイティド Compositions and methods for co-delivery of anti-cancer agents, anti-angiogenic agents, and polysaccharides
US20060074050A1 (en) * 2004-07-14 2006-04-06 Glycogenesys, Inc. Composition and method for treating hyperproliferative diseases
EP1773128A2 (en) * 2004-08-02 2007-04-18 Pro-Pharmaceuticals, Inc. Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins
US9427449B2 (en) * 2005-08-26 2016-08-30 Econugenics, Inc. Binding of galectin-3 by low molecular weight pectin
US8916541B2 (en) * 2011-01-05 2014-12-23 Better Health Publishing, Inc. Synergistic combination of honokiol and modified citrus pectin in cancer therapy
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
CN100394923C (en) * 2006-05-26 2008-06-18 范晓青 Application of low molecular citrus pectin in regulation of blood sugar, blood fat and improvement of fatty liver
CN101269087B (en) * 2007-11-02 2011-11-09 中国人民解放军第四军医大学 Pectin-5-efudix colon cancer double-target prodrug and preparation method
CN102085214A (en) * 2011-01-27 2011-06-08 范晓青 Low-molecular citrus pectin capable of being combined with clinical common chemotherapeutic drug for controlling cancer and cancer metastasis and diffusion
AR086543A1 (en) * 2011-05-25 2014-01-08 Bg Medicine Inc GALECTIN-3 INHIBITORS AND METHODS OF USE OF THE SAME, PHARMACEUTICAL COMPOSITION
HK1201429A1 (en) 2011-10-17 2015-09-04 Butterfly Network Inc. Transmissive imaging and related apparatus and methods
AU2012363033B2 (en) 2011-12-28 2016-06-02 Galectin Therapeutics, Inc. Composition of novel carbohydrate drug for treatment of human diseases
ES2848538T3 (en) 2012-06-06 2021-08-10 Galectin Therapeutics Inc Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with high inducible nitric oxide synthase
DK2900061T3 (en) 2012-09-17 2020-03-02 Galectin Therapeutics Inc PROCEDURE FOR ENHANCING SPECIFIC IMMUNTERPRISES IN CANCER TREATMENT
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
US9339515B2 (en) 2013-02-20 2016-05-17 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
WO2018044242A1 (en) 2016-09-02 2018-03-08 Thailand Centre Of Excellence For Life Sciences Method for preparing an extract of hevea latex and composition thereof
CN116115635A (en) * 2023-03-06 2023-05-16 山东大学 Application of low molecular citrus pectin alone or in combination with platinum drugs in preparation of anti-tumor products

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132577A (en) * 1934-08-28 1938-10-11 Gen Foods Corp Method of preparing pectin
US2036922A (en) * 1935-01-31 1936-04-07 Kelco Co Alginic acid and process of making same
US2791508A (en) * 1952-08-30 1957-05-07 Rivoche Eugene Joel Food products and method of making the same
US2786763A (en) * 1953-01-06 1957-03-26 Rivoche Eugene Joel Food process
US2859115A (en) * 1953-07-07 1958-11-04 Rivoche Eugene Joel Nutrient food products and process of producing same
US3023104A (en) * 1960-07-05 1962-02-27 American Viscose Corp Food compositions incorporating cellulose crystallite aggregates
US3396034A (en) * 1964-01-20 1968-08-06 Motomco Inc Process of converting difficultly dispersible materials into a readily dispersible form and products obtained thereby
US3573058A (en) * 1967-01-30 1971-03-30 Swift & Co Microcrystalline cellulose compositions co-dried with hydrocolloids
US3764707A (en) * 1970-03-04 1973-10-09 Marine Colloids Inc Algin salt-mannogalac- for gum containing aqueous cosmetic lotion
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
GB1474990A (en) * 1974-09-02 1977-05-25 Gen Foods Corp Slow set pectin and process for preparing same
DE2442980A1 (en) * 1974-09-07 1976-03-18 Gen Foods Corp Slow-gelling pectin having reduced calcium sensitivity - prepd by partly demethylating methylated pectin with ammoniacal alcohol soln
JPS5454169A (en) * 1977-10-08 1979-04-28 Asahi Chem Ind Co Ltd Compound
US4263334A (en) * 1978-05-31 1981-04-21 Fmc Corporation Water dispersible cellulosic powder and method of making the same
EP0011891B1 (en) * 1978-11-16 1982-05-19 Unilever N.V. Emulsions and process for their preparation
US4264592A (en) * 1979-01-22 1981-04-28 Kosta Xhajanka Citrus fruit fresh cream
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4268533A (en) * 1979-11-21 1981-05-19 General Foods Corporation Quick-set low methoxyl pectin composition
DE3168085D1 (en) * 1980-11-22 1985-02-14 Unilever Nv Water-in-oil emulsion spread having a fat content ranging from 25 to 65 wt%, which comprises a dispersed aqueous phase containing a gelling system
US4370354A (en) * 1981-12-03 1983-01-25 Hercules Incorporated Stabilized fruit suspensions and method for preparing the same
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
DE3228231A1 (en) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München MEDICINAL PRODUCTS, CALCIUM MIXED SALTS OF POLYMERS, ANIONIC CARBONIC ACIDS AND / OR SULFURIC ACID ESTERS, PROCESS FOR THEIR PRODUCTION AND THEIR USE
US4430349A (en) * 1982-12-23 1984-02-07 The Coca-Cola Company Artificially sweetened gelled yogurt
FR2545101B1 (en) * 1983-04-29 1985-08-16 Agronomique Inst Nat Rech PROCESS FOR MODIFYING BEET PECTINES, PRODUCTS OBTAINED AND THEIR APPLICATIONS
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
JPS61231967A (en) * 1985-04-04 1986-10-16 Ajinomoto Co Inc Food with low fat
US4737582A (en) * 1985-06-28 1988-04-12 The Procter & Gamble Company Absorbent vegetable materials
DK153442C (en) * 1985-10-14 1988-12-19 Poul Bachmann MEDICINE-BASED MATERIALS FOR TREATMENT AND PREVENTION OF HUMAN AND ANIMALS
DE3541945A1 (en) * 1985-11-27 1987-06-04 Lomapharm Rudolf Lohman Gmbh K IMMUNOTIMULATING POLYSACCHARIDES FROM CELL CULTURES FROM ECHINACEA PURPUREA (L.) MOENCH AND ECHINACEA ANGUSTIFOLIA, D.C. PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING IT
AU593618B2 (en) * 1986-03-06 1990-02-15 Unilever Plc Spread
US4686106A (en) * 1986-06-16 1987-08-11 General Foods Corporation Pectin food product
JPS63139108A (en) * 1986-12-02 1988-06-10 Kanebo Ltd Skin cosmetic
US4774095A (en) * 1986-12-16 1988-09-27 The Procter & Gamble Company Filling-containing, dough-based products containing cellulosic fibrils and microfibrils
US4959227A (en) * 1987-02-17 1990-09-25 Amer Moh S High dietary fiber low lactose liquid food and a method of producing same
HK1002915A1 (en) * 1987-02-26 1998-09-25 Bio Polymers Pty. Ltd. Plant gum material and use thereof in food products
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
US4800096A (en) * 1987-05-29 1989-01-24 General Foods Corporation Pectin gelling composition
US4882187A (en) * 1987-07-02 1989-11-21 Thomas J. Lipton Inc. Edible spread and process for the preparation thereof
GB8716111D0 (en) * 1987-07-08 1987-08-12 Unilever Plc Edible plastic dispersion
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
US4828396A (en) * 1987-12-02 1989-05-09 The Nutrasweet Company Fluid processor apparatus
GB8813161D0 (en) * 1988-06-03 1988-07-06 Unilever Plc Emulsions
US4911946A (en) * 1988-06-24 1990-03-27 The Nutra Sweet Company Carbohydrate cream substitute
ATE112663T1 (en) * 1988-06-24 1994-10-15 Nutrasweet Co CARBOHYDRATE CREAM SUBSTITUTE.
US5153020A (en) * 1988-06-24 1992-10-06 The Nutrasweet Company Carbohydrate cream substitute
DK350088D0 (en) * 1988-06-24 1988-06-24 Kobenhavns Pektinfabrik As PROCEDURE FOR IMPROVING THE GEL ESTABLISHMENT PROTECTION GELATING PROPERTIES
EP0355908B1 (en) * 1988-08-17 1996-12-18 Unilever N.V. Liquid based composition comprising gelling polysaccharide capable of forming a reversible gel and a method for preparing such composition
US5071970A (en) * 1988-11-23 1991-12-10 University Of Florida Process for producing pectin with a high-to-medium methoxyl content from beet pulp
US5011701A (en) * 1988-12-30 1991-04-30 Kraft General Foods, Inc. Low calorie food products having smooth, creamy, organoleptic characteristics
EP0430329B1 (en) * 1989-11-22 1995-01-25 Unilever N.V. Fat-continuous dispersion and method of preparing such dispersion
GB8928370D0 (en) * 1989-12-15 1990-02-21 Unilever Plc Fluid composition
US5100688A (en) * 1990-02-23 1992-03-31 Cox James P Saccharide/protein gel
US4988530A (en) * 1990-03-21 1991-01-29 Gerber Products Company Soluble dietary fiber fortified beverage
AU8001191A (en) * 1990-06-19 1992-01-07 G.B. Mars Limited Fat substitutes and method of preparing organic microbeads
JP3013935B2 (en) * 1990-10-19 2000-02-28 コニカ株式会社 Thermal transfer recording medium
FI920721A7 (en) * 1991-02-26 1992-08-27 Hercules Inc Fat substitute
US5374444A (en) * 1991-06-28 1994-12-20 Langner; Bruce J. Fiber beverage and method of manufacture
EP0547647A1 (en) * 1991-11-12 1993-06-23 Unilever N.V. Low fat spreads and dressings
US5238699A (en) * 1991-11-27 1993-08-24 Kraft General Foods, Inc. Ready-to-eat, low/no-fat puddings and process
EP0552503A1 (en) * 1992-01-23 1993-07-28 Romuald Dr. Kowalski Colloidal barium sulphate composition for treating lung neoplasm
ZA931327B (en) * 1992-02-26 1994-08-25 Unilever Plc Water-continuous emulsions based on polysacharides
JP3360899B2 (en) * 1993-10-08 2003-01-07 日本医薬品工業株式会社 Cancer prevention / treatment agent

Also Published As

Publication number Publication date
NO311493B1 (en) 2001-12-03
EP0768885B1 (en) 2004-09-22
EP0768885A1 (en) 1997-04-23
FI965269A0 (en) 1996-12-31
US5895784A (en) 1999-04-20
ATE276753T1 (en) 2004-10-15
DE69533550T2 (en) 2005-09-22
CA2194586A1 (en) 1996-01-25
CN1157567A (en) 1997-08-20
FI965269A7 (en) 1997-03-07
JP2008111002A (en) 2008-05-15
AU2944295A (en) 1996-02-09
AU695677B2 (en) 1998-08-20
US5834442A (en) 1998-11-10
NO970039D0 (en) 1997-01-06
EP0768885A4 (en) 1998-04-29
ES2227555T3 (en) 2005-04-01
BR9508245A (en) 1997-09-30
DK0768885T3 (en) 2004-12-06
PT768885E (en) 2005-01-31
FI965269L (en) 1997-03-07
DE69533550D1 (en) 2004-10-28
MX9700118A (en) 1997-06-28
WO1996001640A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
NO970039L (en) Method of inhibiting cancer metastases by oral administration of soluble modified citrus pectin
DE69830072D1 (en) RADIOACTIVE COMPOSITIONS FOR THE TREATMENT OF PROSTATE TUMORS
ATE415979T1 (en) TREATMENT WITH ANTI-ERBB2 ANTIBODIES
ATE425749T1 (en) TREATMENT OF HER-2/NEW OVEREXPRESSION-ASSOCIATED CANCER
NO993654L (en) Kit for inhibiting cancer growth, comprising a chemotherapeutic agent and a benzimidazole and optionally an enhancer
BG105270A (en) Tetrahydropyridoethers
NO20000752D0 (en) Method of preventing or treating estrogen-dependent diseases and disorders
PL328858A1 (en) Immunogenous peptides
DE59611481D1 (en) Chromatin-regulatorgene
WO2000004954A3 (en) Novel urokinase inhibitors
TR199800270T1 (en) Use of fluconazole in preventing the progression of cancer diseases.
DE69823493D1 (en) TETRAHYDROPYRIDOVERBINDUNGEN
BG101109A (en) Pyridylthio Compounds, A Method For Obtaining And Using Them For Combating Helicobacter Bacteria
EP0951475A4 (en) Vaccine against metastatic colorectal cancer.
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ATE261724T1 (en) ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF POST-TRAAUMATIC STRESS DISEASES
ZA949563B (en) Method for treating aphthae using dimeticone.
FI970330A0 (en) Imidazopyridine azolidinoner
UA30391A (en) Method for treating colorectal cancer
UA10740A (en) Method for combined treatment of gastric cancer
DE59712247D1 (en) MAMMA CARCINOMA ASSOCIATED GEN
UA36341A (en) Method for treating inflammation of periodontal tissues
MY116727A (en) Tetrahydropyrido compounds
UA42301A (en) Camilal remedy for treating and preventing the proctologic disorders